Influence of autologous dendritic cells on the in-vitro expansion and functions of peripheral blood NK cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Immunopharmacology and immunotoxicology

• Publication date

  2015-01-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/08923973.2014.980042PMID 25409754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bringing natural killer cells to the clinic: ex vivo manipulation.

  2013influential reference
• Natural killer cells: a review of manufacturing and clinical utility

  2013cited by this paper
• Impact of HCMV Infection on NK Cell Development and Function after HSCT

  2013cited by this paper
• Therapeutic applications: natural killer cells in the clinic.

  2013cited by this paper
• Autologous stem cell transplant recipients tolerate haploidentical related‐donor natural killer cell–enriched infusions

  2013cited by this paper
• NK Cells are Required for Costimulatory Blockade Induced Tolerance to Vascularized Allografts

  2012cited by this paper
• Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals

  2011cited by this paper
• Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation

  2011cited by this paper
• Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients.

  2010cited by this paper
• Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.

  2009cited by this paper
• Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.

  2009cited by this paper
• [Study on ex vivo expansion of highly purified NK cells from human peripheral blood and changes in their function].

  2009cited by this paper
• Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.

  2009cited by this paper
• [Role of NK cells in allogeneic hematopoietic stem cell transplantation--review].

  2006cited by this paper
• NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect.

  2005cited by this paper
• Role of Interferon-gamma in GVHD and GVL.

  2005cited by this paper
• Use of natural killer cells in hematopoetic stem cell transplantation

  2005cited by this paper
• Ex vivo Expansion of Highly Purified NK Cells for Immunotherapy after Haploidentical Stem Cell Transplantation in Children

  2005cited by this paper
• [Selective expansion of human natural killer cells].

  2005cited by this paper
• Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.

  2005cited by this paper
• [KIR and allogeneic hematopoietic cell transplantation - review].

  2004cited by this paper
• The response of human natural killer cells to interleukin-2.

  2004cited by this paper
• The small subset of CD56brightCD16– natural killer cells is selectively responsible for both cell proliferation and interferon‐γ production upon interaction with dendritic cells

  2004cited by this paper
• Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs.

  2004cited by this paper
• Ex vivo expansion of natural killer cells for clinical applications.

  2004cited by this paper
• Critical Role of MHC Class I-Related Chain A and B Expression on IFN-α-Stimulated Dendritic Cells in NK Cell Activation: Impairment in Chronic Hepatitis C Virus Infection 1

  2003cited by this paper
• Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells

  2002cited by this paper
• Large-Scale Generation of Natural Killer Lymphocytes for Clinical Application

  2002cited by this paper
• Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells

  2002cited by this paper
• Phenotypic changes of T‐lymphocyte subsets induced by interleukin‐12 and interleukin‐15 in umbilical cord vs. adult peripheral blood mononuclear cells

  2001cited by this paper
• Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

  1999cited by this paper
• Differentiation of human dendritic cells from monocytes in vitro

  1997cited by this paper
• Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

  1996cited by this paper
• Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells.

  1995cited by this paper
• A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity.

  1994cited by this paper
• Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity

  1975cited by this paper
• Open Access the Proinflammatory Cytokines Il-2, Il-15 and Il-21 Modulate the Repertoire of Mature Human Natural Killer Cell Receptors

  year unknowncited by this paper

• Proliferation of Highly Functional Human Expanded Natural Killer Cells by Osteoclasts for Cancer Immunotherapy Against OSCSCs

  2016influential citation
• Migratory properties of IL-2 and IL-15 activated Natural Killer Cells in Dendritic Cells and tumor microenvironments

  2015influential citation